Evidence map›Paper›PMID 33517931›Full record

ArticleEuropean psychiatry : the journal of the Association of European Psychiatrists2021

The association between C-reactive protein, mood disorder, and cognitive function in UK Biobank.

David C Milton, Joey Ward, Emilia Ward, Donald M Lyall, Rona J Strawbridge, Daniel J Smith, Breda Cullen

Open access · goldAbstract read
In one paragraph

Article in European psychiatry : the journal of the Association of European Psychiatrists, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Practitioner Review: Infant mental health meets cell and molecular biology - a look to the future.Journal of child psychology and psychiatry, and allied disciplines · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

David C MiltonSchool of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, Scotland.ORCID 0000-0002-8378-6277
Joey WardInstitute of Health and Wellbeing, University of Glasgow, Glasgow, Scotland.
Emilia WardSchool of Life Sciences, University of Glasgow, Glasgow, Scotland.ORCID 0000-0003-1346-179X
Donald M LyallInstitute of Health and Wellbeing, University of Glasgow, Glasgow, Scotland.
Rona J StrawbridgeInstitute of Health and Wellbeing, University of Glasgow, Glasgow, Scotland.ORCID 0000-0001-8506-3585
Daniel J SmithInstitute of Health and Wellbeing, University of Glasgow, Glasgow, Scotland.ORCID 0000-0002-2267-1951
Breda CullenInstitute of Health and Wellbeing, University of Glasgow, Glasgow, Scotland.ORCID 0000-0002-7259-9505
University of Glasgow · GBKarolinska Institutet · SE

Funding

British Heart FoundationCancer Research UKMedical Research Council MC_PC_17217Medical Research Council MR/S003061/1
6 · The paper itself

Abstract

backgroundSystemic inflammation has been linked with mood disorder and cognitive impairment. The extent of this relationship remains uncertain, with the effects of serum inflammatory biomarkers compared to genetic predisposition toward inflammation yet to be clearly established.

methodsWe investigated the magnitude of associations between C-reactive protein (CRP) measures, lifetime history of bipolar disorder or major depression, and cognitive function (reaction time and visuospatial memory) in 84,268 UK Biobank participants. CRP was measured in serum and a polygenic risk score for CRP was calculated, based on a published genome-wide association study. Multiple regression models adjusted for sociodemographic and clinical confounders.

resultsIncreased serum CRP was significantly associated with mood disorder history (Kruskal-Wallis H = 196.06, p < 0.001, η2 = 0.002) but increased polygenic risk for CRP was not (F = 0.668, p = 0.648, η2 < 0.001). Compared to the lowest quintile, the highest serum CRP quintile was significantly associated with both negative and positive differences in cognitive performance (fully adjusted models: reaction time B = -0.030, 95% CI = -0.052, -0.008; visuospatial memory B = 0.066, 95% CI = 0.042, 0.089). More severe mood disorder categories were significantly associated with worse cognitive performance and this was not moderated by serum or genetic CRP level.

conclusionsIn this large cohort study, we found that measured inflammation was associated with mood disorder history, but genetic predisposition to inflammation was not. The association between mood disorder and worse cognitive performance was very small and did not vary by CRP level. The inconsistent relationship between CRP measures and cognitive performance warrants further study.

Indexed as

CognitionC-Reactive ProteinMood DisordersBiological Specimen BanksCohort StudiesGenome-Wide Association StudyHumansUnited KingdomC-Reactive Proteincognitive functionC-reactive proteininflammationmood disorder

Identifiers

PMID33517931
PMCPMC8057439
OpenAlexW3126977293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.